Burning Rock Biotech (BNR) Other Non-Current Liabilities (2020 - 2026)

Burning Rock Biotech (BNR) has reported Other Non-Current Liabilities for 7 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Liabilities rose 18.2% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 18.2% YoY), while the FY2025 annual figure was $1.7 million, up 19.89% from the prior year.
• Other Non-Current Liabilities came in at $1.7 million for Q1 2026 at Burning Rock Biotech, up from $1.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $6.5 million in Q3 2022, with the low at $416000.0 in Q2 2023.
• Average Other Non-Current Liabilities over 5 years is $1.6 million, with a median of $1.5 million recorded in 2024.
• Across the five-year window, Other Non-Current Liabilities jumped 18408.57% in 2022 and slumped 92.67% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $579851.2 in 2022, then advanced by 8.67% to $630132.1 in 2023, then surged by 130.32% to $1.5 million in 2024, then gained by 16.33% to $1.7 million in 2025, then increased by 2.7% to $1.7 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.7 million, $1.7 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.